Physicians’ knowledge about pharmacovigilance in Iraq

Background: Pharmacovigilance plays an essential role in the reduction of adverse drugs reaction (ADRs), thus the evolution and growth of this science are critical for effective and safe clinical practice. Aim: This study will evaluate doctors’ attitudes, barriers and factors encouraging toward A...

Full description

Bibliographic Details
Main Authors: RMS, Muhannad, YA, Arwa, QBA, Omer, Elkalmi, Ramadan Mohamed Mahmod, Kurmanji, Jaafer M
Format: Article
Language:English
Published: OMICS International 2016
Subjects:
Online Access:http://irep.iium.edu.my/51451/
http://irep.iium.edu.my/51451/
http://irep.iium.edu.my/51451/
http://irep.iium.edu.my/51451/1/physicians-knowledge-about-pharmacovigilance-in-iraq-2329-6887-1000214.pdf
id iium-51451
recordtype eprints
spelling iium-514512016-08-08T07:16:11Z http://irep.iium.edu.my/51451/ Physicians’ knowledge about pharmacovigilance in Iraq RMS, Muhannad YA, Arwa QBA, Omer Elkalmi, Ramadan Mohamed Mahmod Kurmanji, Jaafer M RS Pharmacy and materia medica Background: Pharmacovigilance plays an essential role in the reduction of adverse drugs reaction (ADRs), thus the evolution and growth of this science are critical for effective and safe clinical practice. Aim: This study will evaluate doctors’ attitudes, barriers and factors encouraging toward ADRs reporting. Methods: A cross-sectional prospective study has been conducted. It was a psychometric evaluation assessment using a previously modified questionnaire. Results: The majority of the surveyed doctors (78%) believed that reporting adverse drug reactions (ADRs) is part of their duty, and monitoring drug safety is also important (96%). The study findings revealed that about 68% of the doctors felt that they did not have sufficient clinical knowledge to detect ADRs. Nearly two-third of the doctor’s agreed that they are not convinced that the ADRs are caused by the drug. This study show that an association between doctors knowledge about ADRs detection and the number of patient seen by day, as the number of patient increased the doctors knowledge about ADRs improved. Recommendations: Special and direct educational programs, along with continued promotion, could help to enhance the involvement of physicians in ADR reporting and pharmacovigilance activities and help to reduce misconceptions and other logistic barriers to ADR reporting. Further studies with large populations are needed for a better understanding of the actual deterrents which prevent private clinic doctors from reporting ADRs. OMICS International 2016 Article PeerReviewed application/pdf en http://irep.iium.edu.my/51451/1/physicians-knowledge-about-pharmacovigilance-in-iraq-2329-6887-1000214.pdf RMS, Muhannad and YA, Arwa and QBA, Omer and Elkalmi, Ramadan Mohamed Mahmod and Kurmanji, Jaafer M (2016) Physicians’ knowledge about pharmacovigilance in Iraq. Journal of Pharmacovigilance, 4 (3). pp. 1-5. E-ISSN 2329-6887 http://www.esciencecentral.org/journals/physicians-knowledge-about-pharmacovigilance-in-iraq-2329-6887-1000214.pdf 10.4172/2329-6887.1000214
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RS Pharmacy and materia medica
spellingShingle RS Pharmacy and materia medica
RMS, Muhannad
YA, Arwa
QBA, Omer
Elkalmi, Ramadan Mohamed Mahmod
Kurmanji, Jaafer M
Physicians’ knowledge about pharmacovigilance in Iraq
description Background: Pharmacovigilance plays an essential role in the reduction of adverse drugs reaction (ADRs), thus the evolution and growth of this science are critical for effective and safe clinical practice. Aim: This study will evaluate doctors’ attitudes, barriers and factors encouraging toward ADRs reporting. Methods: A cross-sectional prospective study has been conducted. It was a psychometric evaluation assessment using a previously modified questionnaire. Results: The majority of the surveyed doctors (78%) believed that reporting adverse drug reactions (ADRs) is part of their duty, and monitoring drug safety is also important (96%). The study findings revealed that about 68% of the doctors felt that they did not have sufficient clinical knowledge to detect ADRs. Nearly two-third of the doctor’s agreed that they are not convinced that the ADRs are caused by the drug. This study show that an association between doctors knowledge about ADRs detection and the number of patient seen by day, as the number of patient increased the doctors knowledge about ADRs improved. Recommendations: Special and direct educational programs, along with continued promotion, could help to enhance the involvement of physicians in ADR reporting and pharmacovigilance activities and help to reduce misconceptions and other logistic barriers to ADR reporting. Further studies with large populations are needed for a better understanding of the actual deterrents which prevent private clinic doctors from reporting ADRs.
format Article
author RMS, Muhannad
YA, Arwa
QBA, Omer
Elkalmi, Ramadan Mohamed Mahmod
Kurmanji, Jaafer M
author_facet RMS, Muhannad
YA, Arwa
QBA, Omer
Elkalmi, Ramadan Mohamed Mahmod
Kurmanji, Jaafer M
author_sort RMS, Muhannad
title Physicians’ knowledge about pharmacovigilance in Iraq
title_short Physicians’ knowledge about pharmacovigilance in Iraq
title_full Physicians’ knowledge about pharmacovigilance in Iraq
title_fullStr Physicians’ knowledge about pharmacovigilance in Iraq
title_full_unstemmed Physicians’ knowledge about pharmacovigilance in Iraq
title_sort physicians’ knowledge about pharmacovigilance in iraq
publisher OMICS International
publishDate 2016
url http://irep.iium.edu.my/51451/
http://irep.iium.edu.my/51451/
http://irep.iium.edu.my/51451/
http://irep.iium.edu.my/51451/1/physicians-knowledge-about-pharmacovigilance-in-iraq-2329-6887-1000214.pdf
first_indexed 2023-09-18T21:12:50Z
last_indexed 2023-09-18T21:12:50Z
_version_ 1777411366880018432